THE DEAL, AT A GLANCE
From the announcementKaliVir Immunotherapeutics
01What happenedKaliVir Immunotherapeutics raised $14M Series A, announced 2026-08-19From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Why it mattersKaliVir Immunotherapeutics’ $14M Series A extension is a below-median Healthcare & Life Sciences financing in an active 30-day funding window, signaling continued…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
KaliVir Immunotherapeutics · Financing Record
Explore source-linked visual explanations for KaliVir Immunotherapeutics. Unsupported claims are withheld while source review continues.
Record 10544 · Recorded date: 2026-08-19
Explore company records →